Class Action Lawsuit Accuses Drugmakers, Pharmacy Benefit Managers Of Collusion On Price Of Insulin.

reports that a 69-count class action lawsuit has been filed against “leading drugmakers,” such as Sanofi-Aventis, Novo Nordisk and Eli Lilly, and “the country’s three largest pharmacy benefit managers – CVS Health, Express Scripts and OptumRx.” The lawsuit claims that the drugmakers and pharmacy benefit managers “colluded to fix prices for insulin, leading to skyrocketing costs and windfall profits for the companies.” https://www.bna.com/sanofi-cvs-others-n57982085476/